In case of exposure during pregnancy, clinical data are not sufficient to exclude a teratogenic effect of recombinant FSH.
Kliinilised andmed on ebapiisavad välistamaks rekombinantse FSH teratogeenset mõju tahtmatu manustamise korral raseduse ajal.